Does the Selective Progesterone Receptor Modulator Ulipristal Normalize the Uterine Cavity in Women with Leiomyoma

被引：0
|
作者：
Levy, Gary [1 ]
Avila, Nilo [2 ]
Armstrong, Alicia Y. [1 ]
Nieman, Lynnette [1 ]
机构：
[1] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA
[2] NIH, Dept Radiol, Mark O Hatfield Clin Res Ctr, Bethesda, MD 20892 USA
来源：
REPRODUCTIVE SCIENCES | 2011年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
T081
引用
收藏
页码：95A / 95A
页数：1
相关论文
共 50 条
  • [1] Effects of Ulipristal Acetate, a Selective Progesterone Receptor Modulator, on Activin and Myostatin System Expression and Function in Uterine Leiomyoma
    Ciarmela, Pasquapina
    Carrarelli, Patrizia
    Islam, Md Soriful
    Tosti, Claudia
    Castellucci, Mario
    Petraglia, Felice
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 159A - 160A
  • [2] Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate
    Donnez, Jacques
    Donnez, Olivier
    Dolmans, Marie-Madeleine
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (12) : 1679 - 1686
  • [3] Selective Progesterone Receptor Modulator(ulipristal acetate - a new option in the pharmacological treatment of uterine fibroids in women
    Szamatowicz, Marian
    Kotarski, Jan
    GINEKOLOGIA POLSKA, 2013, 84 (03) : 219 - 222
  • [4] Pretreatment of Uterine Fibroids Using a Selective Progesterone Receptor Modulator - Ulipristal Acetate
    Thompson, M.
    Wong, M.
    Opemuyi, I.
    Madipola, N.
    Ramadan, T.
    Nnochiri, A.
    Guttman, J.
    20TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2015, : 205 - 210
  • [5] Progesterone and progesterone receptor modulator in uterine leiomyoma growth
    Maruo, Takeshi
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (04) : 186 - 187
  • [6] Effect of ulipristal acetate, a selective progesterone receptor modulator (SPRM), on fibroid size in women with symptomatic uterine fibroids
    Armstrong, A.
    Nieman, L. K.
    HUMAN REPRODUCTION, 2010, 25 : I90 - I91
  • [7] Endometrial Morphology After Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator, Ulipristal Acetate
    Williams, Alistair R. W.
    Bergeron, Christine
    Barlow, David H.
    Ferenczy, Alex
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (06) : 556 - 569
  • [8] Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
    Szydlowska, Iwona
    Marciniak, Aleksandra
    Nawrocka-Rutkowska, Jolanta
    Ryl, Aleksandra
    Starczewski, Andrzej
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (03)
  • [9] Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
    Szydlowska, Iwona
    Grabowska, Marta
    Nawrocka-Rutkowska, Jolanta
    Kram, Andrzej
    Piasecka, Malgorzata
    Starczewski, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [10] The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor
    Small, Benjamin
    Millard, Charles E. F.
    Kisanga, Edwina P.
    Burman, Andreanna
    Anam, Anika
    Flannery, Clare
    Al-Hendy, Ayman
    Whirledge, Shannon
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 716 - 734
12345